Delivery Order SPE2DB22D2007-SPE2DB25FH8UV
Award Date
2/5/25
Potential Completion Date
2/27/25
Potential Value
$3.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Rituxan Hycela, a 1,400 mg-23,400 11.7 mL medication, with a ceiling value of $7,436.04. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) worth $999,999,999 held by AmerisourceBergen with the DLA, which serves as a primary vehicle for...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Rituxan Hycela 1,400 mg-23,400 11.7 ml. The award, valued at $3,718.02, was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026, which enables the DLA to efficiently procure a comprehensive...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award, valued at $21,639.70, is for the delivery of RITUXAN HYCELA 1,600 MG-26,800 13.4ML, a specialty pharmaceutical product. The contract has an ultimate completion date of February 20, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Office of the Chief Operating Officer, a civilian federal agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $86,641.60, is for the supply of the drug Rituxan 500 mg vials. The contract is a firm fixed-price delivery order, with no set-aside designation, and has an ultimate completion date of September 16, 2015. AmerisourceBergen holds a significant Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $11,738.40 delivery order is for the specialty drug Rituxan Hycela 1,400 mg-23,400 11.7 ML. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by the parent company, Cencora, Inc., which enables efficient procurement of a wide range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,535.52 firm fixed-price delivery order is for the supply of 500mg/50mL vials of the drug Rituximab, which is used to treat certain types of cancer and autoimmune disorders. The contract has an ultimate completion date of September 5, 2024 and was awarded on September 4, 2024. It is not designated as a set-aside contract....
This is a delivery order contract awarded by the Office of the Chief Operating Officer, a civilian federal agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $99,140.57 and is for the delivery of RITUXAN 500MG VL 50ML medical supplies. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, with an ID of SPE2DX15D5017|HHSN269201500480U, was issued by the Office of the Chief Operating Officer, a civilian agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $98,882.60 delivery order contract is for the supply of 500 mg vials of the drug Rituxan to support federal healthcare programs. The contract has a firm fixed price pricing type and an ultimate completion date of July 10, 2015. This award...
This is a $6,359.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RUXIENCE 500 mg/50 ml vials and has an ultimate completion date of January 16, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical for providing a...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a single unit of the pharmaceutical product RITUXAN 500 MG/50 ML VIAL 50ML. The contract has a completion date of February 8, 2024 and a potential value of $6,138.34. This delivery order is likely part of a larger indefinite delivery contract DMS Pharmaceutical Group holds with DLA to supply a variety of...